The results showed that ASCC3, SEMA5A, and JAK1 exhibited higher mutation frequencies across pan-cancer, whereas among specific cancer types, these seven genes had relatively lower mutation frequencies in rectal cancer, but a higher mutation frequency in endometrial cancer (Figures 9C,D). This evidence concerns the gene SEMA5A and endometrial cancer.